Silencing endomucin in bone marrow sinusoids improves hematopoietic stem and progenitor cell homing during transplantation

Yue Li,Miao Ren,Hu Li,Zuo Zhang,Ke Yuan,Yujin Huang,Shengnan Yuan,Wen Ju,Yuan He,Kailin Xu,Lingyu Zeng
DOI: https://doi.org/10.1093/stmcls/sxae046
IF: 5.845
2024-07-13
Stem Cells
Abstract:Efficient homing of infused hematopoietic stem and progenitor cells (HSPCs) into the bone marrow (BM) is the prerequisite for successful hematopoietic stem cell transplantation. However, only a small part of infused HSPCs find their way to the BM niche. A better understanding of the mechanisms that facilitate HSPC homing will help to develop strategies to improve the initial HSPC engraftment and subsequent hematopoietic regeneration. Here, we show that irradiation upregulates the endomucin expression of endothelial cells in vivo and in vitro. Furthermore, depletion of endomucin in irradiated endothelial cells with short interfering RNA (siRNA) increases the HSPC-endothelial cell adhesion in vitro. To abrogate the endomucin of BM sinusoidal endothelial cells (BM-SECs) in vivo, we develop a siRNA-loaded bovine serum albumin nanoparticle for targeted delivery. Nanoparticle-mediated siRNA delivery successfully silences endomucin expression in BM-SECs and improves HSPC homing during transplantation. These results reveal that endomucin plays a critical role in HSPC homing during transplantation and that gene-based manipulation of BM-SEC endomucin in vivo can be exploited to improve the efficacy of HSPC transplantation.
oncology,cell biology,hematology,biotechnology & applied microbiology,cell & tissue engineering
What problem does this paper attempt to address?